Brief: Pfizer And Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated By European Medicines Agency
14/08/2026 06:01
BRIEF-Pfizer And Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated By European Medicines Agency Aug 14 (Reuters) - Pfizer PFE.N:
PFIZER AND VALNEVA’S LYME DISEASE VACCINE CANDIDATE MARKETING AUTHORIZATION APPLICATION VALIDATED BY EUROPEAN MEDICINES AGENCY
: PFIZER AND VALNEVA'S LYME DISEASE VACCINE CANDIDATE MARKETING AUTHORIZATION APPLICATION VALIDATED BY EUROPEAN MEDICINES AGENCY
Source text: ID:nGNXbcryXk
Further company coverage: VLS.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valneva SE
See all newsBrief: UK MHRA Withdraws Marketing Authorisation for Ixchiq Chikungunya Vaccine After Safety Review
Valneva falls as UK regulator revokes Ixchiq vaccine authorisation
Brief: Valneva Provides Update On Ixchiq® In The United Kingdom
Valneva surges after EU regulator validates Lyme disease vaccine application
Brief: Pfizer And Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated By European Medicines Agency